97 related articles for article (PubMed ID: 3002685)
1. Differentiated HL60 promyelocytic leukaemia cells have a deficient myeloperoxidase/halide killing system.
Pullen GR; Hosking CS
Clin Exp Immunol; 1985 Nov; 62(2):304-9. PubMed ID: 3002685
[TBL] [Abstract][Full Text] [Related]
2. Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation.
Newburger PE; Chovaniec ME; Greenberger JS; Cohen HJ
J Cell Biol; 1979 Aug; 82(2):315-22. PubMed ID: 225336
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a human system that generates O2- and induces 8-hydroxydeoxyguanosine, typical of oxidative DNA damage, by a tumor promotor.
Takeuchi T; Nakajima M; Morimoto K
Cancer Res; 1994 Nov; 54(22):5837-40. PubMed ID: 7954411
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
Bendix-Hansen K; Kaspersen Nielsen H
Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866
[TBL] [Abstract][Full Text] [Related]
5. Myeloid differentiated HL-60 cells display specific leukotriene B4 binding sites.
Gorman RR; Ruppel PL; Benjamin CW
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():165-77. PubMed ID: 3028094
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid treated HL60 cells express CEACAM1 (CD66a) and phagocytose Neisseria gonorrhoeae.
Pantelic M; Chen I; Parker J; Zhang P; Grunert F; Chen T
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):261-6. PubMed ID: 15364113
[TBL] [Abstract][Full Text] [Related]
7. Defective chemiluminescence response in differentiated HL60 cells due to impaired degranulation.
Stendahl O; Andersson T; Dahlgren C; Magnusson KE
Biochim Biophys Acta; 1986 May; 881(3):430-6. PubMed ID: 3008851
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the degranulation and myeloperoxidase activity of human polymorphonuclear neutrophils by Brucella melitensis.
Orduña A; Orduña C; Eiros JM; Bratos MA; Gutiérrez P; Alonso P; Rodríguez Torres A
Microbiologia; 1991 Sep; 7(2):113-9. PubMed ID: 1662050
[TBL] [Abstract][Full Text] [Related]
9. Development of calcium and secretory responses in the human promyelocytic leukemia cell line HL60.
Naccache PH; Molski TF; Spinelli B; Borgeat P; Abboud CN
J Cell Physiol; 1984 May; 119(2):241-6. PubMed ID: 6325475
[TBL] [Abstract][Full Text] [Related]
10. Partial myeloperoxidase deficiency in a case of preleukaemia. II. Defects of degranulation and abnormal bactericidal activity of blood neutrophils.
Breton-Gorius J; Houssay D; Vilde JL; Dreyfus B
Br J Haematol; 1975 Jul; 30(3):279-88. PubMed ID: 172112
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells.
Nakazato T; Sagawa M; Yamato K; Xian M; Yamamoto T; Suematsu M; Ikeda Y; Kizaki M
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5436-45. PubMed ID: 17875773
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase secretion during phagocytosis: a case of a patient with impaired bactericidal activity.
Edwards SW; Say JE; Taylor J; Hart CA
J Clin Lab Immunol; 1988 Oct; 27(2):97-102. PubMed ID: 2854568
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of HL-60 promyelocytic leukemia cells: simultaneous determination of phagocytic activity and cell cycle distribution by flow cytometry.
Blair OC; Carbone R; Sartorelli AC
Cytometry; 1986 Mar; 7(2):171-7. PubMed ID: 3456296
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.
Stendahl O; Coble BI; Dahlgren C; Hed J; Molin L
J Clin Invest; 1984 Feb; 73(2):366-73. PubMed ID: 6321554
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin promotes both chemotaxis and haptotaxis in neutrophil-like HL-60 cells.
Mansfield PJ; Suchard SJ
J Immunol; 1993 Mar; 150(5):1959-70. PubMed ID: 8436828
[TBL] [Abstract][Full Text] [Related]
16. Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria.
Henricks PA; van der Tol ME; Verhoef J
Immunology; 1984 Aug; 52(4):671-8. PubMed ID: 6086503
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterisation of dimethylsulphoxide resistant variants from the human promyeloid cell line HL60.
Bunce CM; Fisher AG; Toksoz D; Brown G
Exp Hematol; 1983 Oct; 11(9):828-33. PubMed ID: 6641827
[TBL] [Abstract][Full Text] [Related]
18. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells.
Lane RW; Sturm RJ; Borzelleca JF; Carchman RA
Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690
[TBL] [Abstract][Full Text] [Related]
19. HL-60 cells have abnormal myeloperoxidase transport and packaging.
Bainton DF
Exp Hematol; 1988 Feb; 16(2):150-8. PubMed ID: 2828098
[TBL] [Abstract][Full Text] [Related]
20. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
